Unannounced Meal Challenges Using an Advanced Hybrid Closed-Loop System
Diabetes Technology & Therapeutics · 2023-09 · 25 (9) · 579-588
DOI: 10.1089/dia.2023.0139 ↗Kurz gefasst
Klinische Studie in der Zeitschrift Diabetes Technology & Therapeutics, online erschienen am 23.08.2023. Verfasst von Roy Shalit und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology, Diabetes and Metabolism, Sheba Medical Center, Tel-Hashomer, Israel. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, Hypoglycemia. Die Arbeit wurde bisher 68-mal zitiert (Crossref) und nennt 24 Literaturangaben.
Abstract (Originalsprache)
Background
The advanced hybrid closed-loop (AHCL) algorithm combines automated basal rates and corrections yet requires meal announcement for optimal outcomes. We aimed to compare the performance of the MiniMed™ 780G AHCL algorithm with and without meal announcement.
Methods
In a single-arm study involving 14 adults with type 1 diabetes, we evaluated the safety and efficacy of AHCL when meals were not announced. Participants stayed at a supervised environment for 5 days, during which the outcomes of not announcing meals (≤80 g of carbohydrate) were assessed. Next, participants entered a 90-day at-home “unannounced” phase, during which all meals (≤80 g of carbohydrate) were unannounced, followed by a 90-day at-home phase in which all meals were announced.
Results
Time in range (TIR 70–180 mg/dL) was lower in the unannounced versus announced periods (67.5% ± 12.5% vs. 77.7% ± 9.5%; P < 0.01, respectively), with more time spent in hyperglycemia range 180–250 mg/dL (22.7% ± 7.7% vs. 15.7% ± 7.2%) and >250 mg/dL (7.9% ± 6.4% vs. 3.6% ± 2.7%), but less time in hypoglycemia range 54–70 mg/dL (1.6% ± 1% vs. 2.8% ± 1.8%) and 250 mg/dL, and up to 20 g of unannounced carbohydrates did not significantly change the TIR 70–180 mg/dL compared with full announcement.
Conclusion
The AHCL system is optimized for use with meal announcement. While not announcing meals of ≤80 g carbohydrates appears to be safe, it results in suboptimal postprandial glycemic control, especially with high-carbohydrate meals. Not announcing small meals (≤20 g carbohydrate) does not deteriorate glycemic control. Clinical Trial Registration number: NCT04479826
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Endocrinology, Diabetes and Metabolism, Sheba Medical Center, Tel-Hashomer, Israel.
- Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
- Medtronic, Northridge, California, USA.
ORCID-Profile: Roy Shalit, Ohad Cohen
Zitieren
APA
Shalit, R., Minsky, N., Laron-Hirsh, M., Cohen, O., Kurtz, N., Roy, A., Grosman, B., Benedetti, A., & Tirosh, A. (2023). Unannounced Meal Challenges Using an Advanced Hybrid Closed-Loop System. Diabetes Technology & Therapeutics, 25(9), 579-588. https://doi.org/10.1089/dia.2023.0139
Vancouver
Shalit R, Minsky N, Laron-Hirsh M, Cohen O, Kurtz N, Roy A, et al. Unannounced Meal Challenges Using an Advanced Hybrid Closed-Loop System. Diabetes Technology & Therapeutics. 2023;25(9):579-588. doi:10.1089/dia.2023.0139
BibTeX
@article{Shalit2023,
author = {Shalit, Roy and Minsky, Noga and Laron-Hirsh, Maya and Cohen, Ohad and Kurtz, Natalie and Roy, Anirban and Grosman, Benyamin and Benedetti, Andrea and Tirosh, Amir},
title = {Unannounced Meal Challenges Using an Advanced Hybrid Closed-Loop System},
journal = {Diabetes Technology & Therapeutics},
year = {2023},
volume = {25},
number = {9},
pages = {579--588},
doi = {10.1089/dia.2023.0139}
}
EUVIMED